Exhibit A

 

JOINT FILING AGREEMENT

 

The Undersigned agree that the statement on Schedule 13G with respect to the common stock of OptimizeRx Corporation dated as of January 8, 2025, is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of them pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

 

 

     
 

FIRST LIGHT ASSET MANAGEMENT, LLC

 
       
  By: /s/ Kurt T. Peterson  
  Name: Kurt T. Peterson  
  Title: Chief Compliance Officer  
       
       
  Signature: /s/ Mathew P. Arens  
  Name: Mathew P. Arens  
     

 

 

 

OptimizeRx (NASDAQ:OPRX)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 OptimizeRx 차트를 더 보려면 여기를 클릭.
OptimizeRx (NASDAQ:OPRX)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 OptimizeRx 차트를 더 보려면 여기를 클릭.